The ability to listen is the ability to care. Eko understands how important listening can be for clinicians. We create digital health solutions that enable doctors, nurses, researchers, and entire health systems to change how we care for the heart. Together, we can evolve the science of auscultation and empower the art of caring. Our mission is to enable clinicians with the ability to provide the best cardiac care possible. We are a committed partner to the providers and scientists on the front lines of care.

Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. Eko’s digital stethoscopes enable enhanced listening and precision screening for providers of all types. By digitizing auscultation and ECG recordings, Eko helps providers easily store, analyze, and share patient heart and lung sounds.

Eko Health, Inc. (Eko) is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes and AI detection platform, SENSORA™. The company’s FDA-cleared technologies are used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.